Page last updated: 2024-10-30

mefenamic acid and Bleeding

mefenamic acid has been researched along with Bleeding in 1 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"Primary dysmenorrhea is considered as one of the women's main problems during reproductive age."3.30The effect of vitamin D on the severity of dysmenorrhea and menstrual blood loss: a randomized clinical trial. ( Amzajerdi, A; Ghorbali, E; Keshavarz, M; Pezaro, S; Sarvi, F, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Amzajerdi, A1
Keshavarz, M1
Ghorbali, E1
Pezaro, S1
Sarvi, F1

Trials

1 trial available for mefenamic acid and Bleeding

ArticleYear
The effect of vitamin D on the severity of dysmenorrhea and menstrual blood loss: a randomized clinical trial.
    BMC women's health, 2023, 03-27, Volume: 23, Issue:1

    Topics: Adolescent; Adult; Dysmenorrhea; Female; Hemorrhage; Humans; Iran; Mefenamic Acid; Menstruation; Vit

2023